Dipal Doshi Insider Profile
11 Followers
Dipal Doshi, CEO, Director at Entrada Therapeutics Inc, holds 517.29K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 9.70K shares in Azenta (Ticker: AZTA), holds 1.71K shares in Amicus (Ticker: FOLD).
Dipal Doshi has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dipal Doshi holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Dipal Doshi
Dipal Doshi's Trading History
Entrada Therapeutics Inc
Sep 03, 2026
CEO, Director
Uninformative Sell
62.29K
$3.69M
Azenta
Feb 06, 2026
Director
Uninformative Buy
157.71K
$303.99K
Amicus
Jul 09, 2015
―
Uninformative Sell
86.69K
$24.72K
List of latest transactions for each holding click on a transaction to see Dipal Doshi's performance on stock
You May Also Like
Dipal Doshi insider profile FAQ
What is the percentage of profitable transactions made by Dipal Doshi?
The percentage of profitable transactions made by Dipal Doshi is ―.
What is the average return per transaction made by Dipal Doshi?
The average return per transaction made by Dipal Doshi is ―.
What stocks does Dipal Doshi hold?
Dipal Doshi holds: TRDA, AZTA, FOLD stocks.
What was Dipal Doshi’s latest transaction?
Dipal Doshi latest transaction was an Uninformative Sell of $62.29K.
What was Dipal Doshi's most profitable transaction?
Dipal Doshi’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Dipal Doshi's role in Entrada Therapeutics Inc?
Dipal Doshi's role in Entrada Therapeutics Inc is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.